Oslo, Norway, October 25, 2016 Photocure ASA announced that new data on Blue Light Cystoscopy with Cysview®/Hexvix® were presented at the Société Internationale d’Urologie (SIU) Annual meeting, October 20th to 23rd, Buenos Aires, Argentina: an ePoster from a US registry study and an ePoster video on Blue Light Flexible Cystoscopy.
Photocure ASA announced that a study published on-line in the peer reviewed Journal of Urology, shows that there is no significant statistical difference in the frequency or grade of adverse events in patients having one Blue Light Cystoscopy with Cysview® (BLCC) versus repeat BLCC procedures.
Blue Light Cystoscopy with Cysview® featured on the Cancer Innovations program on ABC TV in New York, NY
Photocure ASA announced today that data from the OPTIC III study: Optimized photodynamic diagnosis for transurethral resection of the bladder tumor (TURBT) in German clinical practice is now available online.
A new systematic review and meta-analysis on the impact of Blue Light Cystoscopy (BLC) with
Hexvix® (Hexaminolevulinate) – versus White Light Cystoscopy (WLC) on progression in Non-Muscle Invasive Bladder Cancer (NMIBC).
New Hexvix kit has an improved design providing healthcare professionals with a simplified and easy-to-use product.
New recommendations promise to enable clinicians to provide more individualized patient care.
The video “Blue Light Cystoscopy with Cysview: The USC Experience” presented by Dr. Sia Daneshmand, MD, is one of the 5 top-viewed videos in the VideoUrology™ Journal.
Oslo, Norway, May 9, 2016 — Photocure ASA announced today new data from a prospective multicenter ongoing registry study that shows Blue Light Cystoscopy (BLC) with Cysview® increases detection rates of flat, more aggressive non-muscle invasive bladder cancer lesions (carcinoma in situ (CIS)) as well papillary lesions over white light cystoscopy (WLC) alone. The data from the prospective registry, real life, study including 175 patients, was presented at the American Urological Association (AUA) annual meeting in San Diego, CA, May 6-10, 2016.
Oslo, Norway, May 2, 2016: Photocure ASA announced today the American Urological Association (AUA) and the Society of Urological Oncology (SUO) have included enhanced cystoscopy in the 2016 Guidelines for the management of non-muscle invasive bladder cancer (NMIBC). Enhanced cystoscopy including Blue Light Cystoscopy (BLC) with Cysview®/Hexvix® is recommended for increasing the detection and reducing recurrence of NMIBC.
